Literature DB >> 19215666

Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software.

Nicolas Fayed1, Pedro J Modrego, Jaime Medrano.   

Abstract

OBJECTIVE: Reproducibility is an essential strength of any diagnostic technique for cross-sectional and longitudinal works. To determine in vivo short-term comparatively, the test-retest reliability of magnetic resonance spectroscopy (MRS) of the brain was compared using the manufacturer's software package and the widely used linear combination of model (LCModel) technique.
METHODS: Single-voxel H-MRS was performed in a series of patients with different pathologies on a 1.5 T clinical scanner. Four areas of the brain were explored with the point resolved spectroscopy technique acquisition mode; the echo time was 35 milliseconds and the repetition time was 2000 milliseconds. We enrolled 15 patients for every area, and the intra-individual variations of metabolites were studied in two consecutive scans without removing the patient from the scanner. Curve fitting and analysis of metabolites were made with the software of GE and the LCModel. Spectra non-fulfilling the minimum criteria of quality in relation to linewidths and signal/noise ratio were rejected.
RESULTS: The intraclass correlation coefficients for the N-acetylaspartate/creatine (NAA/Cr) ratios were 0.93, 0.89, 0.9 and 0.8 for the posterior cingulate gyrus, occipital, prefrontal and temporal regions, respectively, with the GE software. For the LCModel, the coefficients were 0.9, 0.89, 0.87 and 0.84, respectively. For the absolute value of NAA, the GE software was also slightly more reproducible than LCModel. However, for the choline/Cr and myo-inositol/Cr ratios, the LCModel was more reliable than the GE software. The variability we have seen hovers around the percentages observed in previous reports (around 10% for the NAA/Cr ratios).
CONCLUSION: We did not find that the LCModel software is superior to the software of the manufacturer. Reproducibility of metabolite values relies more on the observance of the quality parameters than on the software used.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215666     DOI: 10.1179/174313209X395481

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  12 in total

1.  Neurochemical changes within human early blind occipital cortex.

Authors:  K E Weaver; T L Richards; M Saenz; H Petropoulos; I Fine
Journal:  Neuroscience       Date:  2013-08-14       Impact factor: 3.590

2.  Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.

Authors:  Adriane Gröger; Grzegorz Chadzynski; Jana Godau; Daniela Berg; Uwe Klose
Journal:  Eur Radiol       Date:  2011-04-12       Impact factor: 5.315

Review 3.  Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review.

Authors:  Jeffry R Alger
Journal:  Top Magn Reson Imaging       Date:  2010-04

4.  Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

Authors:  Melissa E Murray; Scott A Przybelski; Timothy G Lesnick; Amanda M Liesinger; Anthony Spychalla; Bing Zhang; Jeffrey L Gunter; Joseph E Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Clifford R Jack; Dennis W Dickson; Kejal Kantarci
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

5.  Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

Authors:  Nicolas Fayed; Javier Garcia-Campayo; Rosa Magallón; Helena Andrés-Bergareche; Juan V Luciano; Eva Andres; Julián Beltrán
Journal:  Arthritis Res Ther       Date:  2010-07-07       Impact factor: 5.156

Review 6.  The evolving role of neurological imaging in neuro-oncology.

Authors:  E J Fontana; T Benzinger; C Cobbs; J Henson; S J Fouke
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

7.  Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.

Authors:  Pedro J Modrego; Nicolas Fayed; Manuel Sarasa
Journal:  BMJ Open       Date:  2011-02-23       Impact factor: 2.692

8.  Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.

Authors:  Daniel Ta; Abdullah Ishaque; Ojas Srivastava; Chris Hanstock; Peter Seres; Dean T Eurich; Collin Luk; Hannah Briemberg; Richard Frayne; Angela L Genge; Simon J Graham; Lawrence Korngut; Lorne Zinman; Sanjay Kalra
Journal:  Neurology       Date:  2021-06-14       Impact factor: 11.800

9.  Cortical and subcortical glutathione levels in adults with autism spectrum disorder.

Authors:  Alice M S Durieux; Jamie Horder; M Andreina Mendez; Alice Egerton; Steven C R Williams; C Ellie Wilson; Debbie Spain; Clodagh Murphy; Dene Robertson; Gareth J Barker; Declan G Murphy; Grainne M McAlonan
Journal:  Autism Res       Date:  2015-08-20       Impact factor: 5.216

10.  Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study.

Authors:  Nicolás Fayed; Yolanda Lopez Del Hoyo; Eva Andres; Antoni Serrano-Blanco; Juan Bellón; Keyla Aguilar; Ausias Cebolla; Javier Garcia-Campayo
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.